Streamlined Resin Y90 Radiation Segmentectomy for Small HCC
NCT06618300 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-11-17
Summary
This single-arm feasibility study evaluating the safety and efficacy of streamlining Yttrium-90 (Y90) radioembolization workflow for patients with small Hepatocellular Carcinoma (\<5cm) that have no aggressive features on baseline imaging. This study aims to recruit N=30 patients prospectively and consolidate the current workflow of 2 days of procedures (1st-day mapping angiography followed by nuclear medicine hepatic lung shunt fraction (LSF) calculation using Tc99-MAA planar and SPECT/CT, and 2nd-day Y90 radioembolization followed by nuclear medicine Y90 SPECT/CT) into 1-day procedure. Several studies have shown that hepatic LSF for HCC tumors smaller than 5cm in the absence of macrovascular invasion and portosystemic shunt placement is invariably \<10%. Therefore, the LSF calculation can be safely omitted from the complex workflow of these patients. This study aims to illustrate that this can be done safely and efficaciously to reduce unnecessary patient travel and healthcare resource utilization. Overall, a total of 30 patients will be included in the study.
Conditions
- Hepatocellular Carcinoma (HCC)
Sponsors & Collaborators
-
Sirtex, Wodburn, MA
collaborator UNKNOWN -
UNC Lineberger Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Hyeon Yu, MD, FSIR · UNC Department of Radiology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-06
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
NCT04518748 ·Status: RECRUITING ·Phase: PHASE1
-
Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option
NCT00740753 ·Status: COMPLETED ·Phase: NA
-
The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy
NCT00774501 ·Status: COMPLETED ·Phase: NA
-
SBRT + TACE for Primary Hepatocellular Carcinoma
NCT00746655 ·Status: WITHDRAWN ·Phase: NA
-
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
NCT01300143 ·Status: COMPLETED ·Phase: PHASE2
-
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
NCT01290536 ·Status: COMPLETED ·Phase: PHASE2
-
Ablative Radioembolization of Renal Cell Carcinoma Trial
NCT06642220 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
NCT03812289 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09
NCT00955175 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic Contrast Enhanced HCC SABR Liver Study
NCT02847767 ·Status: UNKNOWN ·Phase: NA
-
RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry
NCT03516695 ·Status: TERMINATED
-
Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma
NCT04915417 ·Status: UNKNOWN ·Phase: NA
-
Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma
NCT02489838 ·Status: COMPLETED
-
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
NCT00154817 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
NCT07261631 ·Status: RECRUITING ·Phase: PHASE1
-
SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
NCT02221778 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
NCT06595108 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
NCT00911079 ·Status: TERMINATED ·Phase: NA
-
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
NCT05657743 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy (SBRT) for Liver Mets
NCT01360606 ·Status: COMPLETED ·Phase: NA
-
An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer
NCT01514955 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation
NCT06218420 ·Status: RECRUITING ·Phase: PHASE2
-
Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer
NCT00129012 ·Status: COMPLETED ·Phase: PHASE1
-
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
NCT02091050 ·Status: COMPLETED ·Phase: PHASE2
-
Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry
NCT02582034 ·Status: COMPLETED ·Phase: PHASE2